An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Inclusion Criteria

• •Must have met the eligibility criteria and have been enrolled in the qualified Phase 2 or 3 parent studies listed below or other qualified region-specific studies and meet the following additional criteria:
• •1. Participants previously enrolled in Study APD334-301 (NCT03945188) or APD334-210 (NCT04607837) must have completed the Week 12 visit and have been assessed to have active UC that has not improved or has worsened from baseline or completed the Week 52 visit
• •2. Participants previously enrolled in APD334-302 (NCT03996369) must have completed the Week 12 visit